NDATOPICALLOTION
Approved
May 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 22h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID (hydrocortisone butyrate) is a topical corticosteroid lotion approved for inflammatory skin conditions. It works by suppressing local immune and inflammatory responses in dermatological indications. The product is administered as a lotion for direct application to affected skin areas.
LOE Approaching
As LOE approaches, commercial teams face revenue pressure and consolidation; expect focus on cost optimization and managed transition strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on LOCOID offers experience in mature brand management and dermatological market dynamics, but limited career growth potential given the LOE trajectory. Professionals should expect transition planning, cost management, and market defense strategies as core responsibilities.
Brand ManagerProduct Manager
Worked on LOCOID at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.